Medicenna Therapeutics Corp.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CA58490H1073

CAD

1.56

-0.04 (-2.5%)

Dec 04

TSE

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Rapid Dose Therapeutics Corp.

Avicanna, Inc.

Microbix Biosystems, Inc.

Ceapro, Inc.

Oncolytics Biotech, Inc.

Cardiol Therapeutics, Inc.

FSD Pharma, Inc.

Medicenna Therapeutics Corp.

Sernova Corp.

BriaCell Therapeutics Corp.

Cognetivity Neurosciences Ltd.

Why is Medicenna Therapeutics Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Medicenna Therapeutics Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Medicenna Therapeutics Corp.

-6.02%

-0.16

71.88%

S&P/TSX 60

19.1%

1.54

14.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-183.72%

EBIT to Interest (avg)

-17.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.30

Sales to Capital Employed (avg)

Tax Ratio

9.40%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.02%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.81

EV to EBIT

-2.16

EV to EBITDA

-2.17

EV to Capital Employed

-8.68

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-141.81%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at CAD -11.77 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-16What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CAD -17.72 MM

PRE-TAX PROFIT(Q)

At CAD -6.21 MM has Fallen at -72.59%

NET PROFIT(Q)

Lowest at CAD -6.21 MM

Here's what is working for Medicenna Therapeutics Corp.

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medicenna Therapeutics Corp.

Pre-Tax Profit

At CAD -6.21 MM has Fallen at -72.59%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -6.21 MM has Fallen at -72.59%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Operating Cash Flow

Lowest at CAD -17.72 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Net Profit

Lowest at CAD -6.21 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)